Annals of Emergency Medicine
Volume 50, Issue 6 , Pages 745-746 , December 2007

Octreotide Therapy for Nateglinide-Induced Hypoglycemia

References 

  1. Schiling H, Shuya W, Barbara F, et al. Pancreatic beta-cell K-ATP channel activity and membrane-binding studies with nateglinide: a comparison with sulfonylureas and repaglinide. J Pharmacol Exp Ther. 2000;293:444–452
  2. Fonseca VA, Kelley DE, Cefalu W, et al. Hypoglycemic potential of nateglinide versus glyburide in patients with Type 2 diabetes mellitus. Metabolism. 2004;53:1331–1335
  3. Nakayama S, Hirose T, Watada H, et al. Hypoglycemia following a nateglinide overdose in a suicide attempt. Diabetes Care. 2005;28:227–228
  4. Nagai T, Imamura M, Iizuka K, et al. Hypoglycemia due to nateglinide administration in a diabetic patient with chronic renal failure. Diabetes Research and Clinical Practice. 2003;59:191–194
  5. McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med. 2000;36:133–138

PII: S0196-0644(07)01260-7

doi: 10.1016/j.annemergmed.2007.06.490

Annals of Emergency Medicine
Volume 50, Issue 6 , Pages 745-746 , December 2007

Article Tools